Scarica l'app Stockscreener
19.87
0.30%
-0.06
Dopo l'orario di chiusura:
19.87
Caredx Inc Borsa (CDNA) Ultime notizie
(CDNA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
EV Market: Can CareDx Inc maintain sales growthJuly 2025 Snapshot & Low Drawdown Trading Techniques - baoquankhu1.vn
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference - BioSpace
Is CareDx (CDNA) Quietly Redefining Its Moat With AlloHeme’s Early Relapse Detection Breakthrough? - Yahoo Finance
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Beh - GuruFocus
Zweig DiMenna Associates LLC Buys 348,400 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx (CDNA) Projected to Post Earnings on Tuesday - MarketBeat
CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT - Zacks Investment Research
Does ACROBAT AlloHeme Validation Broaden CareDx’s (CDNA) Transplant+ Thesis Into Hematology-Oncology? - simplywall.st
Assessing CareDx (CDNA) Valuation After Positive AlloHeme Clinical Validation Results - Yahoo Finance
CareDx Seeks High Court Review Of $45M False Ad Case - Law360
CareDx Announces Clinical Validation Results for AlloHeme, the First AI-Powered NGS Surveillance Solution for AML and MDS Post-Cell Therapy - marketscreener.com
CareDx Expands “Transplant Plus” Into Cell Therapy, Showcases AlloHeme AML/MDS Relapse Data - MarketBeat
Page not foundAirwhon - MarketBeat
Panic Selling: Will CareDx Inc (1K9) stock benefit from infrastructure billQuarterly Trade Review & Risk Managed Investment Strategies - mfd.ru
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy - 01net
CareDx, Inc. $CDNA Stock Holdings Lessened by New York State Common Retirement Fund - MarketBeat
US Market Wrap: Whats the RSI of CareDx Inc stockJuly 2025 Movers & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - ChartMill
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Insider Trends: What is the dividend yield of CareDx IncJuly 2025 Patterns & AI Enhanced Trading Alerts - baoquankhu1.vn
Liquidity Mapping Around (CDNA) Price Events - Stock Traders Daily
CareDx (NASDAQ:CDNA) Cut to "Hold" at Wall Street Zen - MarketBeat
Can CareDx (CDNA) Turn AlloHeme’s ACROBAT Data Into a Durable Precision-Transplant Moat? - simplywall.st
Lobbying Update: $15,000 of CAREDX lobbying was just disclosed - Quiver Quantitative
Short Covering: Can CareDx Inc keep up with sector leadersChart Signals & Free Reliable Trade Execution Plans - baoquankhu1.vn
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings - BioSpace
Momentum Shift: Will CareDx Inc stock benefit from M AWeekly Trend Summary & Reliable Volume Spike Alerts - baoquankhu1.vn
RSI Check: Will First Busey Corporation outperform small cap indexes2025 Price Targets & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Price Action: Does FDMT align with a passive investing strategyMarket Trend Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
CareDx CEO Sells Nearly 20,000 Shares in Open Market Transactions - Intellectia AI
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 - The Globe and Mail
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 - The Motley Fool
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? - Yahoo Finance
CareDx President and CEO Sells 19,000 Shares for $412,000 - The Globe and Mail
CareDx, Inc. $CDNA is Gagnon Advisors LLC's 8th Largest Position - MarketBeat
CareDx, Inc. $CDNA Position Increased by Gagnon Securities LLC - MarketBeat
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Chartmill
Can CareDx Inc deliver consistent dividendsDollar Strength & Advanced Swing Trade Entry Alerts - mfd.ru
Death Cross: Is CareDx Inc a play on infrastructure spendingCPI Data & AI Based Buy and Sell Signals - baoquankhu1.vn
Aug Update: Can CareDx Inc beat the S P 5002025 Volume Leaders & High Yield Equity Trading Tips - baoquankhu1.vn
Is CareDx’s Upgraded 2025 Revenue Outlook Altering The Investment Case For CareDx (CDNA)? - Sahm
CareDx CEO Hanna sells $412,222 in shares By Investing.com - Investing.com India
CareDx CEO Hanna sells $412,222 in shares - Investing.com
Insider Sell: Hanna John Walter JR Sells Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 19,280 Shares - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Innovator With 4.66% Upside Potential - DirectorsTalk Interviews
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 10,156 Shares - MarketBeat
Tech Rally: What is the dividend yield of CareDx IncJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
Sentiment Review: Can CareDx Inc generate free cash flow2025 Winners & Losers & Community Verified Trade Alerts - baoquankhu1.vn
0.95%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):